Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
TPI-1 is effective starting at 10 ng/mL in increasing SHP-1 phospho-substrates pLck-pY394
CCG-222740 markedly decreased SRF reporter gene activity and showed a greater inhibitory effect on MRTF/SRF target genes than the previously described MRTF-A inhibitor CCG-203971
Smiles: OC1(CN2CCC(COC3=NOC4=CC=CC(O[C@H]5COCC5)=C43)CC2)CCOCC1
Zorifertinibum
which has antivirus and antitumor ability
Fidaxomicin lite N-Demethyl Ivabradine Hydrochloride TPI-1 is effective starting atFidaxomicin is the first in a new class of narrow spectrum macrocyclic antibiotic drugs. It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis. Fidaxomicin is non systemic, meaning it is minimally absorbed into the bloodstream, it is bactericidal, and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that
US$ 2975.00
US$ 37.71
US$ 178.23
US$ 89.78
US$ 14.39
US$ 137.50